1018978-91-0 Usage
General Description
(S)-7-Fluorochroman-4-amine is a chemical compound that belongs to the class of organic compounds known as aminochromanes. It is a derivative of chromanamine and is a fluorinated compound, meaning it contains a fluorine atom. (S)-7-Fluorochroman-4-amine has potential pharmacological properties and biological activities, although its specific uses and effects have not been extensively studied. Its molecular structure contains a chroman ring with an amine group and a fluorine atom attached to it, which may play a role in its interactions and activities. Further research is needed to fully understand the potential applications and implications of (S)-7-Fluorochroman-4-amine.
Check Digit Verification of cas no
The CAS Registry Mumber 1018978-91-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,8,9,7 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1018978-91:
(9*1)+(8*0)+(7*1)+(6*8)+(5*9)+(4*7)+(3*8)+(2*9)+(1*1)=180
180 % 10 = 0
So 1018978-91-0 is a valid CAS Registry Number.
1018978-91-0Relevant articles and documents
BICYCLIC UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF PAIN
-
, (2014/06/11)
Compounds of Formula I: or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis and pelvic pain syndrome.
8-SUBSTITUTED 2-(BENZIMIDAZOLYL)PURINE DERIVATIVES FOR IMMUNOSUPPRESSION
-
Page/Page column 9, (2008/06/13)
The present invention provides novel purines useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula I:
